Ara
Toplam kayıt 2, listelenen: 1-2
Impairment of patient-reported outcomes among patients with non-alcoholic fatty liver disease: a registry-based study
(Wiley, 2022)
Background Patients with non-alcoholic fatty liver disease (NAFLD) and more advanced fibrosis tend to have more impairment in their health-related quality of life and other patient-reported outcomes (PROs). Aim To assess ...
An international multidisciplinary consensus statement on MAFLD and the risk of CVD
(Springer, 2023)
Background Fatty liver disease in the absence of excessive alcohol consumption is an increasingly common condition with a global prevalence of similar to 25-30% and is also associated with cardiovascular disease (CVD). ...